These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 11888025)
1. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Chatrath R; Porter CB; Ackerman MJ Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025 [TBL] [Abstract][Full Text] [Related]
2. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262 [TBL] [Abstract][Full Text] [Related]
3. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286 [TBL] [Abstract][Full Text] [Related]
4. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116 [TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up. Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378 [TBL] [Abstract][Full Text] [Related]
6. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314 [TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related]
9. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196 [TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties. Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479 [TBL] [Abstract][Full Text] [Related]
11. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111 [TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator implantation in children in The Netherlands. Ten Harkel AD; Blom NA; Reimer AG; Tukkie R; Sreeram N; Bink-Boelkens MT Eur J Pediatr; 2005 Jul; 164(7):436-41. PubMed ID: 15843980 [TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillators in children. Werner B; Przybylski A; Kucińska B; Lewandowski M; Szwed H; Wróblewska-Kałuzewska M Kardiol Pol; 2004 Mar; 60(3):239-46. PubMed ID: 15156219 [TBL] [Abstract][Full Text] [Related]
14. Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death. Stabile G; D'Agostino C; Gallo P; Marrazzo N; Iuliano A; De Simone A; Turco P; Palella M; Donnici G; Ciardiello C; Napolitano G; Solimene F J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):110-3. PubMed ID: 22367567 [TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications. Vriesendorp PA; Schinkel AF; Van Cleemput J; Willems R; Jordaens LJ; Theuns DA; van Slegtenhorst MA; de Ravel TJ; ten Cate FJ; Michels M Am Heart J; 2013 Sep; 166(3):496-502. PubMed ID: 24016499 [TBL] [Abstract][Full Text] [Related]